NAFLD patients (n = 144) | p value* | |||
---|---|---|---|---|
PNPLA3 genotype | CC (n = 55) | CG (n = 68) | GG (n = 21) | |
Age (years) | 49±13 | 51±12 | 47±12 | 0.87 |
Sex (F) | 15 (27) | 12 (18) | 5 (24) | 0.58 |
BMI (Kg/m2) | 26.8±3.7 | 27.1±3.1 | 26.0±3.0 | 0.62 |
ALT (IU/ml) | 54±38 | 58±49 | 80±54 | 0.06 |
Diabetes | 3 (5.5) | 11 (16.2) | 3 (14.3) | 0.13 |
Insulin (IU/ml) | 14.6 {11.7-19.9} | 13.4 {10.2-20.2} | 16.8 {11.5-22.1} | 0.33 |
Glucose | 94±21 | 101±34 | 97±16 | 0.43 |
HOMA-IR | 3.1 {2.5-4.5} | 3.3 {2.4-4.5} | 3.3 {2.4-5.5} | 0.57 |
FFAs (mmol/l) | 0.21±0.09 | 0.22±0.08 | 0.22±0.09 | 0.85 |
Adipo-IR | 14.2±15.1 | 13.9±13.9 | 17.9±15.4 | 0.78 |
Adiponectin (μg/ml) | 5.5 {3.0-9.9} | 4.9 {3.0-7.4} | 3.8 {2.7-6.5} | 0.03 |
Controls (n = 257) | p value* | |||
PNPLA3 genotype | CC (n = 146) | CG (n = 95) | GG (n = 16) | |
Age (years) | 46±12 | 51±12 | 45±14 | 0.51 |
Sex (F) | 37 (25) | 15 (16) | 3 (19) | 0.83 |
BMI (Kg/m2) | 24.8±2.7 | 25.2±2.8 | 25.2±4.2 | 0.71 |
ALT (IU/ml) | 21±7 | 24±8 | 22±6 | 0.48 |
Insulin° (IU/ml) | 11.8 {9.5-14.0} | 11.9 {9.2-15.4} | 9.0 {7.6-14.8} | 0.17 |
Glucose | 89±6 | 89±6 | 86±3 | 0.89 |
HOMA-IR° | 2.5 {1.9-3.2} | 2.6 {2.0-3.4} | 1.8 {1.7-3.0} | 0.10 |
FFAs° (mmol/l) | 0.16±0.07 | 0.14±0.06 | 0.23±0.02 | 0.93 |
Adipo-IR° | 6.4±2.8 | 5.2±2.1 | 8.1±0.9 | 0.47 |
Adiponectin (μg/ml) | 7.0 {4.7-9.9} | 6.2 {4.7-8.8} | 5.6 {4.2-7.4} | 0.04 |